Previous Article | Next Article ![]()
Journal of Bacteriology, December 2007, p. 9020-9029, Vol. 189, No. 24
0021-9193/07/$08.00+0 doi:10.1128/JB.01238-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
,
Canada Research Chair on Bacterial Animal Diseases, Université de Montréal, Faculté de Médecine Vétérinaire, Saint-Hyacinthe, Québec, Canada
Received 31 July 2007/ Accepted 2 October 2007
|
|
|---|
|
|
|---|
AIDA-I belongs to the family of monomeric autotransporter proteins, a branch of the type V secretion pathway (11). Most autotransporter proteins identified so far are proven or predicted virulence factors (10). AIDA-I is synthesized as a preproprotein with a molecular mass of approximately 145 kDa and has a modular organization, like all autotransporters (1). The N terminus of the preproprotein corresponds to a sec-dependent sequence signal consisting of 49 amino acids. Cleavage of the sequence signal results in release of the proprotein in the periplasm. The proprotein comprises two different domains (34): the 100-kDa surface-exposed mature AIDA-I protein and a 45-kDa membrane-embedded domain, AIDAc. The latter is believed to form a pore in the outer membrane which may serve as the translocation conduit for mature AIDA-I towards the cell surface. Mature AIDA-I is cleaved after secretion, presumably by an autocatalytic event (34), but it remains strongly associated with AIDAc (1, 4).
Recently, AIDA-I has been proposed to be a member of a new group of autotransporter proteins called self-associating autotransporters (SAATs) (16). This group also includes Ag43, a surface protein widely distributed among pathogenic and nonpathogenic strains of E. coli and responsible for bacterial aggregation (27), and TibA, an adhesin/invasin of enterotoxigenic E. coli (5). These proteins share sequence similarities, are all glycosylated by specific heptosyltransferases that can be functionally exchanged, and possess the same multiple properties likely to be important for virulence of pathogenic strains: the ability to mediate bacterial aggregation, biofilm formation, and invasion of and adhesion to cultured epithelial cells (3, 9, 20, 22, 31-33). A structure-function study of Ag43 has been performed (15), and it revealed that the domain responsible for the aggregation phenotype resides within the N-terminal 160 residues and is distinct from the domain allowing biofilm formation. Indeed, nonaggregative variants of Ag43 could still mediate attachment to abiotic surfaces. Ag43 can also mediate adhesion to and invasion of epithelial cells (7, 31), but no region related to these phenotypes has been identified so far. In addition, this kind of analysis has never been conducted with AIDA-I or TibA. Therefore, more information is required to better understand the molecular basis of SAAT multifunctionality.
In the present report, we describe a mutagenesis study of AIDA-I. We used random transposon scanning mutagenesis and construction of a domain deletion mutant in order to identify regions in mature AIDA-I involved in the various phenotypes associated with the expression of this protein. Our data revealed that the N-terminal third of the protein is specifically involved in attachment to cultured epithelial cells. We also identified other mutations that affect each of the other functions of AIDA-I. The existence of mutants with mutations that altered invasion but not adhesion and vice versa, as well as a mutant with a mutation that altered autoaggregation but not biofilm formation and vice versa, suggested that these phenomena involve distinct mechanisms. Taken together, our results provide new insights into the mechanism of action of the SAAT group of autotransporters.
|
|
|---|
To construct five-amino-acid insertion mutants, the pAngH plasmid was randomly mutagenized using the GPS-LS linker scanning system (New England Biolabs) according to the instructions of the manufacturer. The presence of an insertion was assessed by PCR. Plasmids with insertions were transformed in E. coli strain C600. DNA sequencing was used to determine the insertion sequence and its precise location.
The
N,
C,
C2, and
NC deletions were introduced into pAngH by oligonucleotide-directed mutagenesis performed with a QuikChange II site-directed mutagenesis kit (Stratagene) using the primers listed in Table 1 and the corresponding complementary oligonucleotides, which generated pAngH
N (deletion of amino acids 54 to 225), pAngH
C (deletion of amino acids 224 to 637), pAngH
C2 (deletion of amino acids 224 to 667), and pAngH
NC (deletion of amino acids 54 to 667). To generate glutathione S-transferase (GST) fused to AIDAN (the N-terminal portion of mature AIDA-I), a fragment of the aidA gene corresponding to amino acids 50 to 224 was amplified by performing PCR with primers that introduced BamHI and XhoI restriction sites (Table 1). The DNA fragment was digested with BamHI and XhoI and cloned at the same sites into the pGex-4T-1 vector (Amersham Biosciences) to create pGex-AIDAN.
|
View this table: [in a new window] |
TABLE 1. Primers used in this study
|
Heat extraction. Heat extracts were obtained as previously described (4). Briefly, overnight cultures of E. coli C600 bearing appropriate plasmids were normalized to the same OD600 in 10 ml of LB broth. Bacteria were harvested and resuspended in 150 µl of 10 mM sodium phosphate buffer (pH 7). In order to release mature AIDA-I, the samples were heated at 60°C for 20 min. The treated samples were centrifuged for 5 min at 12,000 x g in microcentrifuge tubes. A 10-µl sample from each supernatant was subjected to sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) and stained with Coomassie blue, as described below.
Whole-cell lysates. Overnight cultures (10 ml) were grown, normalized, and centrifuged for 10 min at 12,000 x g in microcentrifuge tubes, and the pellets were resuspended in 100 µl of phosphate-buffered saline (PBS). All samples were processed by performing SDS-PAGE and immunoblotting as described below.
SDS-PAGE, immunoblotting, and detection of glycans. Protein samples were diluted in 2x SDS-PAGE loading buffer containing β-mercaptoethanol and denatured by heating at 100°C for 10 min. The samples were then separated by SDS-PAGE on 10 or 12% acrylamide gels. The gels were either stained with Coomassie blue or transferred to polyvinylidene fluoride membranes (Millipore). Immunodetection was performed with a serum raised against heat-extracted mature AIDA-I (a generous gift from M. Ngeleka, University of Saskatchewan) diluted 1:10,000 in blocking buffer (5% skim milk, 50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 0.05% Triton X-100). A goat anti-rabbit horseradish peroxidase (HRP)-conjugated antibody (Sigma) was used as a secondary antibody according to the instructions of the manufacturer. Alternatively, an anti-HisG HRP-coupled antibody (Invitrogen) diluted 1:5,000 in blocking buffer was used for detection of proteins containing the HisG tag. Immune complexes were revealed using a 3,3',5,5'-tetramethylbenzidine solution for membranes (Sigma). Glycosylation was detected using a digoxigenin-hydrazine labeling glycan detection kit (Roche) according to the instructions of the manufacturer.
Protein purification. For purification of GST fusion proteins, 1-liter cultures of BL21 harboring plasmid pGex-4T-1, pGex-AIDAN, or pGex-AIDAN and pAah were grown until the OD600 was 0.4 and induced with 10 µM IPTG for 3 h. Bacteria were harvested, resuspended in 40 ml of Tris-buffered saline (50 mM Tris-HCl [pH 8], 150 mM NaCl) containing lysozyme (final concentration, 0.4 mg·ml–1) and EDTA (pH 8) (final concentration, 10 mM), and lysed with a French press and an ultrasonic processor. The soluble fraction was isolated by 30 min of centrifugation at 16,000 x g.
For AIDA-I purification, 1-liter cultures of C600 harboring plasmids pAngH and pAah were grown until the OD600 was 0.8 and then were induced overnight with 10 µM IPTG. The cells were lysed as described above, and each lysate was centrifuged for 1 h in an ultracentrifuge at 250,000 x g. The membranes were resuspended in Tris-buffered saline containing 1% Triton X-100, incubated for 1 h, and centrifuged again. The solubilized membranes contained histidine-tagged native AIDA-I.
The proteins were purified using an ÄKTA purifier system with a 5-ml glutathione Sepharose column or with a 1-ml His Trap HP column (Amersham Biosciences) according to the instructions of the manufacturer. The purity of the purified proteins was confirmed by SDS-PAGE and staining with Coomassie blue.
Functional assays. Autoaggregation, biofilm formation, adhesion, and invasion assays were performed as previously described (4). In the autoaggregation assay, cultures of E. coli C600 harboring the pTRC99A vector, plasmids pAah and pAngH, or plasmid pAah and plasmid pAngH bearing a mutation were normalized in 10 ml of LB to an OD600 of approximately 1.5 in culture tubes and left to stand at 4°C. Samples (200 µl) were taken 1 cm below the surface at the beginning of the assay and after 180 min, and the OD600 of the samples were measured. In the biofilm formation assay, normalized cultures of C600 were grown in M9 minimal medium for 24 h at 30°C in plastic microtiter plates. Biofilms were stained with crystal violet. The fixed dye was solubilized with a mixture of ethanol and acetone (80:20), and the absorption at 595 nm of the solution was measured. In the adhesion and invasion assays, cultures of C600 were inoculated onto monolayers of confluent HEp-2 cells in a 24-well plate (approximately 2.5 x 105 cells) using 106 CFU per well. After 3 h, the cells were washed with PBS, and the adhering bacteria were recovered, plated, and counted. In the invasion assay, fresh medium containing gentamicin, penicillin, and streptomycin was added after the 3 h, and the preparations were incubated for an additional 2 h before plating. For 1 x106 CFU (total number) of bacteria expressing wild-type AIDA-I, the maximum level of adhesion was 7.9 x104 CFU and the maximum level of invasion was 2.3 x102 CFU.
All functional assays were performed at least three times in duplicate or triplicate. For each assay, the means of the results obtained with each mutant were compared to the mean obtained with the wild-type control by performing an analysis of variance and Dunnet posttests using the Prism 4.0 software (Graphpad Software).
Cell-based ELISA. HEp-2 cells were grown to confluence in a 96-well plate and fixed for 15 min with PBS containing 2.5% paraformaldehyde and 0.2% glutaraldehyde. After one wash with PBS, the plate was blocked with 3% bovine serum albumin in PBS for 2 h at 37°C. Native glycosylated AIDA-I, GST, unglycosylated GST-AIDAN, and glycosylated GST-AIDAN fusion proteins were added to the cells at concentrations ranging from 300 pM to 1 µM and incubated overnight at 4°C. After extensive washes with PBS, bound proteins were detected with an HRP-coupled antibody raised against GST or against native AIDA-I diluted 1:10,000 in PBS (Amersham Biosciences). Immune complexes were revealed using a 3,3',5,5'-tetramethylbenzidine solution in an enzyme-linked immunosorbent assay (ELISA) (Sigma). The background value was subtracted, and the absorption intensities were normalized by dividing the absorption of each well by the maximal intensity measured on the plate. Experiments were conducted in duplicate at least twice. Binding curves and dissociation constants were obtained by nonlinear regression fitting to a one-binding-site hyperbola curve, using Prism 4.0 (Graphpad Software).
Immunofluorescence microscopy. HEp-2 cells were grown to confluence in a Lab-Tek II chamber slide (Nalge Nunc International). After one wash with PBS, proteins (GST, unglycosylated GST-AIDAN, or glycosylated GST-AIDAN) were added to the cells at a concentration of 1 µM and incubated at 37°C for 1 h. After four washes with PBS, the cells were fixed for 15 min with PBS containing 2.5% paraformaldehyde and 0.2% glutaraldehyde, and the plate was blocked with 3% bovine serum albumin in PBS for 1 h at 37°C. Bound proteins were detected with an antibody raised against GST diluted 1:1,000 in PBS-2% bovine serum albumin. Immune complexes were revealed by incubation with a donkey anti-goat immunoglobulin G-rhodamine red conjugate and examination of the microscopic slides with a fluorescence and phase-contrast Leica DMI4000B microscope (Meyer Instruments).
|
|
|---|
The mutagenesis procedure yielded 60 different insertions distributed throughout mature AIDA-I. Twenty-nine of these insertions did not affect protein expression, as assessed by immunoblotting of whole-cell lysates with an antibody against the HisG tag (data not shown). The insertion sites and the inserted sequences in these mutants are shown in Table S1 in the supplemental material. The remaining 31 insertions, which disrupted protein expression, were discarded. One reason for discarding these insertions is that the mutagenesis procedure left a PmeI restriction site whose translation resulted in a TAA stop codon in two of the six possible frames. Many of the insertions that resulted in a lack of protein expression were probably due to this introduction of a stop codon and therefore would not have been informative. Alternatively, some of the insertion mutations could have resulted in an unstable protein.
As described below, the function of 11 of the 29 insertion mutants was affected. We examined in greater detail the expression of these mutants, as well as a mutant that was not affected by the insertion (I8) as a control. As shown in Fig. 1, the 100-kDa mature AIDA-I was observed in whole-cell lysates of all mutant bacteria, and it was correctly located at the cell surface, as shown by the release of mature AIDA-I in the supernatant after brief heating at 60°C (1). Moreover, mature AIDA-I of all the mutants appeared at a molecular weight that represented the glycosylated form of the protein, and it could be detected with the anti-AIDA-I antiserum, which recognizes only the glycosylated protein (3). Based on these observations, we concluded that all of the insertion mutants expressed glycosylated AIDA-I, although it was still possible that the extent of glycosylation might have been slightly different in different mutants. This is in agreement with our recent finding that glycosylation is highly heterogeneous and occurs at many sites throughout AIDA-I (4a). These results therefore suggest that the insertions did not affect biogenesis, including the glycosylation status, or the structure of AIDA-I; in other words, these results suggest that these sites are structurally permissive for insertions. For the I2 and I20 mutants, however, two distinct additional bands in the whole-cell lysates reacted with the antibody against mature AIDA-I or against the HisG tag (Fig. 1A and B). These two polypeptides could also be released in the culture supernatant after brief heat treatment (Fig. 1C). N-terminal sequencing was used to identify the cleavage sites. Cleavage of both mutant proteins occurred at the transposon insertion site, between a lysine and a histidine (see Table S1 in the supplemental material). Since the additional cleavage sites were introduced by the inserted sequences and the proteins were only partially processed, we concluded that the structural integrity of these proteins was most likely not affected dramatically.
![]() View larger version (48K): [in a new window] |
FIG. 1. Effect of insertions on the expression of AIDA-I. Whole-cell lysates were obtained from overnight cultures of C600 harboring an empty vector (lane –), plasmid pAngH (lane WT), or one of the plasmids bearing a five-amino-acid insertion in pAngH. Bacteria harboring pAngH plasmids also contained the pAah plasmid, which allowed production of the AIDA-I-specific glycosyltransferase, Aah. Proteins separated by SDS-PAGE were probed by immunoblotting with an antiserum against mature AIDA-I (A) or with an antibody against the HisG tag (B) which allowed detection of the proprotein (Pro.) (132 kDa) and mature AIDA-I (100 kDa). (C) Cultures of strain C600 harboring the same plasmids were heat extracted at 60°C for 20 min. The heat extracts were resolved by SDS-PAGE and stained with Coomassie blue. The asterisks indicate additional cleavage sites in AIDA-I resulting from the inserted sequence (see text for details). MW, molecular mass.
|
![]() View larger version (34K): [in a new window] |
FIG. 2. Effect of insertion mutants on the functionality of AIDA-I. Bacteria bearing an empty vector (bars –) or expressing wild-type (bars WT) or mutated AIDA-I proteins were tested for the presence of several phenotypes. (A) Autoaggregation assay. Cultures were left standing at 4°C, and the OD600 at the top of the culture was measured at the beginning of the assay (light gray bars) and after 180 min (dark gray bars). (B) Biofilm formation assay. Biofilms formed in microtiter plates were stained with crystal violet, and the amount of fixed dye was measured by determining the absorption at 595 nm. (C) Adhesion and invasion assays. Bacteria that adhered to HEp-2 cells were directly plated and counted. The number of intracellular bacteria was estimated by assessing the resistance to external antibiotics. The data are the percentages of adhesion or invasion compared to bacteria expressing wild-type AIDA-I. Significant differences (P < 0.05) are indicated by asterisks for aggregation and biofilm formation (A and B) and by open circles for adhesion and filled circles for invasion (C). The difference in biofilm formation mediated by I4 was not statistically significant (NS).
|
![]() View larger version (16K): [in a new window] |
FIG. 3. Schematic diagram of the insertion mutations in AIDA-I and the related phenotypes: locations and effects of the mutations obtained from linker scanning mutagenesis. The open arrows indicate the insertion mutants without a functional defect, whereas the filled arrows indicate mutants with a defect for one or more functions. The filled box represents the HisG tag at the N terminus of mature AIDA-I.
|
Deletion of a putative cell-binding domain in mature AIDA-I. Five insertion mutants with mutations clustered in the N-terminal third of mature AIDA-I affected the adhesion mediated by the protein, suggesting that there is a cell-binding domain in this region. In order to complement these results, we constructed a mutant with the N-terminal third of mature AIDA-I between residues G54 and A225 deleted (the former residue corresponds to the fourth residue of mature AIDA-I, and the latter residue corresponds to the transposon insertion site in mutant I7 [Fig. 4A]).
![]() View larger version (31K): [in a new window] |
FIG. 4. Deletion of putative cell-binding domain in mature AIDA-I. (A) Schematic diagram of the deletion construct, showing plasmids pAngH (WT) and pAngH N ( N). The filled box represents the HisG tag at the N terminus of mature AIDA-I. (B) Whole-cell lysates of bacteria harboring an empty vector (lane –), expressing wild-type AIDA-I (lane WT), or expressing the N mutant (lane N) were obtained and probed with anti-HisG antibodies, which allowed detection of the proprotein (circles) and mature AIDA-I (arrowheads). All plasmids were transformed in bacteria expressing the Aah glycosyltransferase. (C) Heat extracts of the same cultures were obtained, resolved by SDS-PAGE, and stained with Coomassie blue. (D) Detection of glycosylation, using the digoxigenin glycan detection kit, performed with whole-cell lysates. MW, molecular mass.
|
N mutant were checked by probing whole-cell lysates with antibodies against the HisG tag. As shown in Fig. 4B, a specific polypeptide with a molecular mass slightly greater than 75 kDa was apparent in proteins extracted from bacteria expressing the
N mutant, which is consistent with the expected size of the mature
N mutant (63 kDa) with glycosylation. This hypothesis was confirmed by detection of sugar using a glycan detection kit. The reaction of the
N mutant with the digoxigenin-hydrazine label was identical to that of the wild-type protein (Fig. 4D). In another study, we identified 16 residues of mature AIDA-I which can be modified by heptose molecules (4a). Only four of these residues are located between G54 and A225. This finding therefore explains the fact that the
N mutant was still glycosylated. Additionally, we performed heat extraction of bacteria expressing the
N mutant to verify the correct location of the protein at the cell surface (Fig. 4C). Again, a polypeptide of the expected size was apparent, without any degradation product. These assays showed that the
N mutant was as well expressed, glycosylated, and stable as the wild-type protein.
To assess the effects of this deletion on the functionality of AIDA-I, the four functional assays performed above were conducted again (Fig. 5). Deletion of the N-terminal third of mature AIDA-I did not affect the ability of the protein to mediate bacterial aggregation or biofilm formation (Fig. 5A and B). This suggests that the regions of AIDA-I involved in biofilm formation and autoaggregation are not located in the N-terminal third of the mature protein. However, the
N mutant was considerably less able to mediate binding to cultured epithelial cells (Fig. 5C). This is in agreement with the results of the linker scanning mutagenesis analysis that indicated that the ability of mutants I1, I2, I4, I5, and I6 to mediate adhesion was affected. This appears to contradict the hypothesis that there is a secondary cell-binding site. It should be noted, however, that the level of invasion by bacteria expressing the
N mutant was marginally lower than the level of invasion by bacteria expressing wild-type AIDA-I (Fig. 5D). This result shows that the
N mutant has a low level of cell-binding ability, consistent with the hypothesis that two regions are important for adhesion. The difference in the extents to which adhesion and invasion are affected is also similar to observations made with the I4, I23, and I24 mutants (Fig. 2C).
![]() View larger version (18K): [in a new window] |
FIG. 5. Function of AIDA-I bearing the N deletion. An autoaggregation assay (A), a biofilm formation assay (B), an adhesion assay (C), and an invasion assay (D) were performed with cultures of C600 bearing an empty vector (bar –), plasmids pAngH and pAah (bar WT), or plasmids pAngH N and pAah (bar N). The assays were performed as described in the legend to Fig. 2. NS, not significant.
|
N mutant or were not expressed at all (data not shown), suggesting that the biogenesis, the stability at the cell surface, and/or the global conformation of these mutated proteins may have been disturbed. It is therefore likely that the C-terminal repeats of mature AIDA-I play a more important role in the biogenesis or the structural integrity of the protein. Since these defects were likely to influence the functional assays of the mutants, we decided not to test their functions. N-terminal domain of mature AIDA-I, glycosylated or not glycosylated, is sufficient to mediate binding to cultured epithelial cells. To confirm that the N-terminal third of mature AIDA-I is involved in the adhesion to epithelial cells, we fused this region, corresponding to residues A50 to G224, to GST. Using affinity chromatography, we purified the GST protein alone as a control and the unglycosylated and glycosylated forms of the GST-AIDAN fusion protein by coexpression with or without the Aah glycosyltransferase (Fig. 6A). The GST-AIDAN fusion protein encompasses four glycosylation sites that we identified. The glycosylation status of this protein was confirmed with a glycan detection kit (Fig. 6B). In order to demonstrate the binding properties of the N-terminal third of mature AIDA-I, we developed a cell-based ELISA. As shown in Fig. 6C, unglycosylated and glycosylated GST-AIDAN fusion proteins bound in a saturable manner to the HEp-2 cells with equilibrium dissociation constants of 84 and 72 nM, respectively. By comparison, we observed that whole glycosylated AIDA-I could bind to the cells with a dissociation constant of 3 nM. This value is in agreement with the dissociation constant (2 nM) obtained in another study performed with the mature protein (19). The higher dissociation constants obtained with the fusion proteins (84 and 72 nM, compared to 2 or 3 nM for whole AIDA-I) could have been due to the presence of the GST moiety blocking accessibility to cellular receptors, to the difficulty of purifying a fusion protein as stable as the native protein, or to the possible presence of two binding sites in mature AIDA-I, as suggested by the results of our mutagenesis analysis.
![]() View larger version (41K): [in a new window] |
FIG. 6. Cell-binding properties of glycosylated (Glyc.) and unglycosylated (Unglyc.) GST-AIDAN. (A) Coomassie blue-stained SDS-PAGE gel of the purification products from the soluble fraction of strain BL21 bearing plasmid pGex-4T-1, pGex-AIDAN, or pGex-AIDAN and pAah obtained by performing affinity chromatography with a glutathione Sepharose column. The arrowheads indicate the position of the purified protein. (B) Detection of glycosylation of the purified proteins using the digoxigenin glycan detection kit. (C) Cell-based ELISA. HEp-2 cells were grown in a 96-well plate and, after fixation and blocking, were incubated with various concentrations of whole AIDA-I ( ), GST (x), unglycosylated GST-AIDAN (), or glycosylated GST-AIDAN ( ). Bound proteins were detected with an antibody against GST or AIDA-I coupled to HRP. The activity of HRP was measured using a colorimetric substrate by monitoring absorption at 450 nm. The background value was subtracted, and the absorption was normalized by dividing the absorption of each well by the maximal absorption measured on the plate in order to obtain percentages of maximal binding. MW, molecular mass.
|
![]() View larger version (71K): [in a new window] |
FIG. 7. Immunofluorescence detection of purified unglycosylated (Unglyc.) and glycosylated (Glyc.) GST-AIDAN on the surface of epithelial cells. Purified GST, unglycosylated GST-AIDAN, and glycosylated GST-AIDAN fusion proteins were added to confluent HEp-2 cells at a concentration of 1 µM and incubated at 37°C for 1 h. After binding of the proteins, the cells were washed, fixed, and blocked with bovine serum albumin before detection of bound proteins with antibody raised against GST. Immune complexes were revealed by incubation with a donkey anti-goat immunoglobulin G-rhodamine red conjugate.
|
|
|
|---|
![]() View larger version (62K): [in a new window] |
FIG. 8. Locations of the five-amino-acid insertions in AIDA-I. (A) Sequence of the N-terminal part of the passenger domain of AIDA-I showing the imperfectly repeated 19-amino-acid motif repeated 35 times. The positions of the insertion mutations are indicated. The circles indicate the positions of the identified glycosylation sites (4a). (B) Weblogo (http://weblogo.berkeley.edu/) representation of the repeated motif, showing the relative conservation of each amino acid of the consensus. Each repeat of this motif is thought to correspond to a coil of a β helix and is predicted to consist of three β strands, as previously modeled (13). The positions of the strands, with the original nomenclature of the model, are indicated. (C) Locations of the five-amino-acid insertions in the coil model. A filled circle represents an isoleucine, valine, or leucine residue, and "X" indicates any residue. The open squares represent insertions that did not affect the functions of AIDA-I. The shaded squares indicate insertions that disrupted one or more of the functions.
|
As shown in Fig. 8C, the β2 strands seemed to harbor more of the insertions that did not affect function, whereas the β1 strands seemed to be more important for the functionality of the protein, as five of the six insertions in these strands disrupted one or more functions related to the expression of AIDA-I. This observation raises the possibility that the functionality of AIDA-I might be localized predominantly on one of the faces of the β helix. In this respect, we noticed that the mutations affecting adhesion and/or invasion are clustered in β1 strands and, to a lesser extent, in β2 and β3 strands, whereas the mutations that affect biofilm formation or autoaggregation are in β2 strands. This could suggest that the interactions with eukaryotic cells involve primarily the face of the β helix formed by the β1 strands, whereas autoaggregation or biofilm formation requires the face formed by the β2 strands.
The main conclusion of our study is that a cell-binding domain is present in the N-terminal third of mature AIDA-I. First, we identified five different insertions in this N-terminal region that resulted in a deficiency in adhesion to cultured epithelial cells. Second, AIDA-I with a deletion of the amino acids between G54 and A225 was unable to mediate adhesion to HEp-2 cells. Finally, the N-terminal region (between A50 and G224) fused to GST could efficiently bind to epithelial cells, as assessed by a cell-based ELISA and by immunofluorescence microscopy. The fusion protein could bind whether it was glycosylated or not. The observation that glycosylation is not required for binding is in agreement with our recent finding that glycosylation of AIDA-I is required to ensure the normal conformation of the protein and therefore might only indirectly affect the adhesion to epithelial cells (4a). Based on the known structures of other autotransporters (6, 12, 26), the N-terminal location of the primary binding domain of AIDA-I could make the interaction with a host cell receptor easier, as this part of the protein is farther away from the cell surface. The presence of a cell-binding domain at the N-terminal end of a bacterial adhesin has been reported before, for instance in the case of the Yersinia enterocolitica trimeric autotransporter adhesin YadA (28).
We also identified in the C-terminal half of mature AIDA-I three other insertion mutations that resulted in a reduction in the adhesion phenotype. Our results therefore suggest that this protein possesses two binding domains, one in the N-terminal third and one in the C-terminal half. The presence of different binding domains in the same adhesin has been described previously, for instance in trimeric autotransporters such as Haemophilus influenzae Hia (18) and in the E. coli Dr adhesin (17). As mentioned above, we noticed that most insertions affecting adhesion were located in the predicted β1 strands and to a lesser extent in the predicted β3 strands. The two faces of the β helix formed by these strands might therefore harbor the two different binding sites. Alternatively, the insertions in the C-terminal half of the protein could indirectly affect the N-terminal cell-binding domain. For instance, the N and C termini of the repeats might be spatially close in the three-dimensional structure. More work is required to distinguish between these possibilities.
Our results further suggest that invasion and adhesion rely on different mechanisms. Indeed, we identified three insertion mutants, I9, I12, and I13, which mediated binding to epithelial cells as well as the wild-type protein but were unable to mediate invasion. Invasion mediated by AIDA-I is therefore likely not to be just the effect of passive uptake by cultured epithelial cells; rather, it seems to rely on a specific mechanism. Bacteria expressing the I4, I23, and I24 insertion mutants or the
N deletion mutant exhibit impaired adhesion but only slightly reduced invasion. These results suggest that the binding to a receptor involved in adhesion could be different from the interactions responsible for invasion. Similarly, it was recently observed that variants of the YadA trimeric autotransporter with reduced binding to laminin exhibited greater binding to fibronectin and resulted in an increase in integrin-mediated invasion (8).
Finally, we obtained two mutants (I9 and I24) whose abilities to mediate autoaggregation and biofilm formation were not correlated; a nonaggregative mutant could mediate biofilm formation and vice versa. Separation of these two a priori related phenotypes has also been noted for Ag43 (15). Collectively, these studies therefore support the idea that biofilm formation mediated by AIDA-I involves more than the ability of bacterial cells to interact with one another.
A more precise picture of the AIDA-I autotransporter emerged from our study. Given the similarity that AIDA-I shares with Ag43 and TibA, our results are likely to apply to these and other putative SAAT proteins and shed new light on how these versatile proteins participate in the pathogenesis of diarrheagenic E. coli.
Published ahead of print on 12 October 2007. ![]()
Supplemental material for this article may be found at http://jb.asm.org/. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»